Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous devices for stroke prevention.

Yves L Bayard1, Stefan H Ostermayer, Ralph Hein

  • 1CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany.

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|September 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for bipolar hemiarthroplasty dislocation: a retrospective cohort study.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2026
Same author

Prophylactic Effects of Combined Bosentan and Nintedanib on Early Post-Traumatic Joint Contracture Formation in a Rat Model.

Journal of clinical medicine·2026
Same author

Dual Endothelin Receptor Inhibition with Bosentan Does Not Prevent the Early Formation of Post-Traumatic Joint Contracture in a Rat Model.

Journal of clinical medicine·2025
Same author

Nintedanib reduces severity of post-traumatic joint contracture by modulating fibrosis and inflammation.

Journal of molecular medicine (Berlin, Germany)·2025
Same author

Correction: High prevalence of p16 staining in malignant tumors.

PloS one·2025
Same author

Early Hip Fracture Surgery in Patients Taking Direct Oral Anticoagulants Improves Outcome.

Journal of clinical medicine·2024
Same journal

Post-market safety profile of the CardioMEMS HF System: A MAUDE disproportionality and network analysis.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Editorial: That's why it's called "hardening of the arteries". The challenge of PCI in calcified coronary arteries.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Incidence and prognostic value of electrocardiographic changes in patients with myocardial injury after elective PCI.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Eyeballing versus comprehensive geriatric frailty assessment and outcomes after transcatheter aortic valve replacement: Insights from a large cohort.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

An assessment of the accuracy of a novel peripheral artery disease scoring system to identify obstructive coronary artery disease in patients with severe aortic stenosis.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Lipoprotein(a) testing in invasive coronary angiography: Screening yield and anatomic coronary disease burden.

Cardiovascular revascularization medicine : including molecular interventions·2026
See all related articles

Catheter-based stroke prevention focuses on patent foramen ovale (PFO) closure for cryptogenic stroke and left atrial appendage (LAA) occlusion for atrial fibrillation (AF). New devices show promise, though large trials are pending.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Cerebral ischemia, particularly stroke, poses a significant health challenge.
  • Catheter-based interventions are emerging as key strategies for stroke prevention.
  • Patent foramen ovale (PFO) and left atrial appendage (LAA) are critical targets.

Purpose of the Study:

  • To review current catheter-based techniques for stroke prevention.
  • To discuss the latest devices for PFO closure and LAA occlusion.
  • To highlight new developments in catheter-based stroke prevention.

Main Methods:

  • Review of current literature on catheter-based stroke prevention devices.
  • Analysis of techniques for PFO closure and LAA occlusion.
  • Examination of results from nonrandomized studies and emerging device data.

Related Experiment Videos

Main Results:

  • Several new devices for PFO closure and LAA occlusion have been developed.
  • Nonrandomized studies indicate promising results for these device-based therapies.
  • Randomized trial data comparing device therapy with antiplatelet or anticoagulation is not yet available.

Conclusions:

  • Catheter-based PFO closure and LAA occlusion are important strategies for preventing cerebral ischemia.
  • Ongoing research and device development are advancing catheter-based stroke prevention.
  • Further randomized trials are needed to establish definitive therapeutic comparisons.